相关实验视频

Updated: Jan 10, 2026

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

氧化应激和肝硬化严重程度:对预测和相互作用影响与炎症的回顾性队列分析

Vlad Pădureanu¹, Lidia Boldeanu², Denisa Floriana Vasilica Pîrșcoveanu³

¹Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.

|November 26, 2025

概括

氧化应激标志物,如甲 (MDA) 不能独立预测肝硬化结局. 已建立的临床标志物,特别是白蛋白和INR,仍然是优越的预测因素,尽管氧化应激与疾病严重程度有关.

科学领域:

生物化学生物化学
临床医学临床医学
病理生理学病理生理学

背景情况:

氧化应激与肝硬化病原因有关.
氧化应激标志物的临床意义相对于已确立的肝硬化预测因素是不清楚的.

研究的目的:

评估氧化应激标志物 (马隆迪甲基和8-epi-prostaglandin F2α) 在预测肝硬化患者的结果中的临床意义.
为了比较氧化应激标志物的预测能力与已建立的临床和生化参数.

主要方法:

90名住院肝硬化患者的回顾性队列研究.
在入院时评估临床数据,生化参数,炎症指数和氧化应激标志物 (MDA,8-epi-PGF2α).
统计分析包括后勤回归,ROC分析和决策曲线分析 (DCA).

主要成果:

较高的甲酸 (MDA) 水平与晚期肝脏脑病 (HE3) 相关联.
氧化应激标志物与白蛋白 (AUC 0.74-0.90) 和INR (AUC 0.72-0.88) 相比,显示出适度的区分能力 (AUC 0.55-0.60).
白蛋白和INR是最强的独立预测因素;氧化标志物缺乏独立的预测能力,但与疾病严重程度相关.

结论:

已经确立的临床标志物如白蛋白和INR是肝硬化结果的主导预测因素.
氧化应激标记不提供独立的预测价值,但具有生物学相关性,与疾病严重程度和炎症相关.

关键词:

在INR中,INR就是INR.专辑蛋白 (albumin) 是一种这是一种炎症炎症炎症炎症.肝硬化是肝硬化的一种疾病.氧化应激是一种氧化应激.

更多相关视频

Analyzing Oxidative Stress in Murine Intestinal Organoids using Reactive Oxygen Species-Sensitive Fluorogenic Probe

Analyzing Oxidative Stress in Murine Intestinal Organoids using Reactive Oxygen Species-Sensitive Fluorogenic Probe

Published on: September 17, 2021

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...